Last reviewed · How we verify
NCT04458441: w-pi
Can Warm Skin Disinfection Reduce the Pain Peripheral Central Catheter Application in Premature Babies?
NA trial testing warm group/cold group in Pain, Acute in 30 participants. Status unknown.
5 September 2022
Quick facts
| Lead sponsor | Zekai Tahir Burak Women's Health Research and Education Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 30 |
| Start date | 5 May 2020 |
| Primary completion | 5 September 2022 |
| Estimated completion | 30 December 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- warm group/cold group
Conditions studied
- Pain, Acute — all drugs for Pain, Acute →
- Premature — all drugs for Premature →
Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Who can join
Under 1 Month, any sex, with Pain, Acute or Premature. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Peripheral central catheter application, especially in extremely low birth weight premature babies, is an intensive care follow-up procedure. There are many clinical studies in areas such as catheter type, skin disinfection, catheter duration, catheter infection. In our practice, it was observed that premature baby was less uncomfortable, the number of trials decreased, and the change in body temperature was less with the application of hot skin disinfection in our practice. With a prospective randomized study, the investigators wanted to document their observational data scientifically.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04458441
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pain, Acute
Currently open trials in the same condition.
- NCT07249827 — A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guid · Phase 2 · recruiting
- NCT07053774 — Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain · Phase 2 · recruiting
- NCT07009951 — Impact of Virtual Reality in Cardiac Electrophysiology · recruiting
- NCT06960317 — Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements · NA · recruiting
- NCT06754657 — CORA-Q15: Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery · Phase 4 · recruiting
Other Zekai Tahir Burak Women's Health Research and Education Hospital trials
Trials by the same sponsor.
- NCT06540014 — The Difference of Weight Gain Tendencies and Obesity During Pregnancy · completed
- NCT04009551 — Epidemiology, Treatment and Prognosis of Neonatal Meningitis in Turkey: A Multicenter Study · unknown
- NCT03675425 — The Effects of Phototherapy in Preterm Infants Pda · NA · unknown
- NCT03655457 — Evaluation of the Efficacy of Surfaktant in Preterm Infants by Lung Ultrasound · NA · unknown
- NCT03591835 — Endotracheal Tube Placement in Neonatal Intubation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04458441 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zekai Tahir Burak Women's Health Research and Education Hospital
- Last refreshed: 8 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04458441.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing